Dabur Q3 Update: Revenue Guidance Slashed on Weak Beverage & Health Sales

CONSUMER-PRODUCTS
Whalesbook Logo
AuthorVihaan Mehta|Published at:
Dabur Q3 Update: Revenue Guidance Slashed on Weak Beverage & Health Sales
Overview

Dabur India's Q3 FY26 update signals mid-single digit revenue growth, below prior expectations, with healthcare and beverages underperforming. Home and Personal Care shows strength, and international markets fare well, but investors weigh category concerns against improving rural sentiment.

Guidance Cut Amid Category Weakness

Dabur India's business update for the third quarter of fiscal year 2026 indicated mid-single digit consolidated revenue growth, a revision downward from earlier guidance of mid-to-high single digits for the second half of FY26. Profit growth is projected to outpace revenue expansion.

The company's domestic business saw robust double-digit growth in Home and Personal Care (HPC), while the healthcare segment is expected to post only low-single digit sequential growth. This performance falls below consensus expectations for both healthcare and beverages. Management attributes the muted beverage performance to adverse seasonality, although the premium 'Real Activ' range continues to drive growth. Favorable macroeconomic conditions and tax reforms are anticipated to support a demand recovery, particularly in rural markets where the rebound is stronger.

Home & Personal Care Shines

Within HPC, strong performance was driven by hair oils and oral care, with many portfolio items outpacing category growth and suggesting market share gains for Dabur. The Dabur Amla, Dabur Almond, Dabur Anmol, Dabur Red Toothpaste, and Meswak franchises experienced volume-led growth. Distribution channels like organized trade, e-commerce, and quick commerce also maintained growth momentum, posting double-digit increases.

Healthcare, Beverages Lag Expectations

While specific healthcare drivers such as Dabur Honey, Honitus, and health juices are estimated to have grown 15% year-on-year, the overall healthcare category growth is expected to be in low single digits. Hajmola and Ethicals could see mid-single digit growth. Primary sales for Chyawanprash remain muted, though secondary sales are positive with a Q4 pickup anticipated. Foods & Beverages, excluding the culinary business which saw double-digit growth, faced challenges, with nectars and drinks underperforming.

International Footprint Expands

The international business is poised for near double-digit growth in rupee terms. Key markets in the Middle East, North Africa (MENA), Turkey, and Bangladesh performed well. Dabur's US-based Namaste hair care brand, acquired in 2010, also contributed positively to overseas performance. Overall, the international segment is expected to deliver low double-digit growth.

Outlook Hinges on Rural Rebound

Dabur has faced growth challenges over the last 4-6 quarters, leading to guidance cuts and a derating of valuation multiples. Analysts note that the current update, while disappointing in some segments, benefits from a low base year-on-year and positive consumer sentiment, especially a stronger rural rebound. A favorable resolution of the ongoing Namaste litigation is also seen as a potential upside, although sustained weakness in hair oil, health supplements, and beverages remains a concern. Despite these headwinds, analyst reactions appear to be positive, with focus shifting to the potential for recovery.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.